https://www.istegroup.com/fr/produit/cancers-vers-une-revolution-therapeutique/?utm_source=emailing&utm_medium=mailkitchen&utm_campaign=Cancer%202409
Radionuclide candidates for β+γ coincidence PET: An overview, Sitarz M, Cussonneau J-P, Matulewicz T, Haddad F., Applied Radiation and Isotopes. janv 2020;155:108898. https://doi.org/10.1016/j.apradiso.2019.108898
Production of polonium from bismuth and purification using TBP resin and Sr resin, Younes A, Alliot C, Ali JS, Bonraisin A-C, Mokili M, Happel S, et al., J Radioanal Nucl Chem. mai 2020;324(2):823‑8. https://doi.org/10.1007/s10967-020-07109-5
CERN-MEDICIS: a unique facility for the production of nonconventional radionuclides for the medical research, Duchemin C, Ramos JP, Stora T, Aubert E, Audouin N, Barbero E, et al., In: 11th International Particle Accelerator Conference [Internet]. Caen, France; 2020.
Disponible sur: https://hal.archives-ouvertes.fr/hal-03013154
Nanomedicine for Nuclear Imaging and drug delivery: what needs of characterization for what challenges?, S. Huclier, 22 Novembre 2019, Colorado Schools of Mines, Golden (Colorado, USA)
Theranostic Radiopharmaceuticals : at the Inflection Point, Jean-François Chatal, Françoise Bodere-Kraeber, Caroline Rousseau, Ferid Haddad, British Journal of Cancer Research, 2019, 2 (2), pp.264-269.
Very high specific activity erbium 169Er production for potential receptor-targeted radiotherapy, Formento-Cavaier R, Köster U, Crepieux B, Gadelshin VM, Haddad F, Stora T, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:468‑71. https://doi.org/10.1016/j.nimb.2019.04.022